Tim Rahmel

1.4k total citations
40 papers, 468 citations indexed

About

Tim Rahmel is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tim Rahmel has authored 40 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tim Rahmel's work include Sepsis Diagnosis and Treatment (16 papers), Ion Transport and Channel Regulation (6 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Tim Rahmel is often cited by papers focused on Sepsis Diagnosis and Treatment (16 papers), Ion Transport and Channel Regulation (6 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Tim Rahmel collaborates with scholars based in Germany, Austria and United States. Tim Rahmel's co-authors include Michael Adamzik, Jürgen Peters, Hartmuth Nowak, Katharina Rump, Lars Bergmann, Björn Koos, Ulrich H. Frey, Matthias Unterberg, Simon Schäfer and Simone Kreth and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tim Rahmel

37 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Rahmel Germany 13 130 118 91 83 67 40 468
Min He China 14 50 0.4× 199 1.7× 34 0.4× 45 0.5× 58 0.9× 39 546
Sung‐Hee Hwang South Korea 13 69 0.5× 139 1.2× 36 0.4× 43 0.5× 43 0.6× 33 527
Yves Ouellette United States 13 253 1.9× 93 0.8× 59 0.6× 41 0.5× 118 1.8× 35 619
Ole Koldkjær Denmark 13 82 0.6× 274 2.3× 69 0.8× 89 1.1× 109 1.6× 20 797
Jérémie Joffre France 15 97 0.7× 155 1.3× 76 0.8× 126 1.5× 34 0.5× 30 542
Purificación Ros Spain 12 91 0.7× 180 1.5× 64 0.7× 26 0.3× 140 2.1× 22 636
Shiro Mishima Japan 12 55 0.4× 52 0.4× 69 0.8× 72 0.9× 105 1.6× 38 491
Jakob Müller Germany 12 57 0.4× 92 0.8× 45 0.5× 71 0.9× 141 2.1× 44 544
Satoru Kawano Japan 14 38 0.3× 57 0.5× 81 0.9× 48 0.6× 47 0.7× 67 564
Qianqian Zhu China 14 84 0.6× 43 0.4× 58 0.6× 31 0.4× 51 0.8× 42 463

Countries citing papers authored by Tim Rahmel

Since Specialization
Citations

This map shows the geographic impact of Tim Rahmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Rahmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Rahmel more than expected).

Fields of papers citing papers by Tim Rahmel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Rahmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Rahmel. The network helps show where Tim Rahmel may publish in the future.

Co-authorship network of co-authors of Tim Rahmel

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Rahmel. A scholar is included among the top collaborators of Tim Rahmel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Rahmel. Tim Rahmel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rump, Katharina, Björn Koos, Tim Rahmel, et al.. (2024). Methazolamide Reduces the AQP5 mRNA Expression and Immune Cell Migration—A New Potential Drug in Sepsis Therapy?. International Journal of Molecular Sciences. 25(1). 610–610. 5 indexed citations
2.
Nowak, Hartmuth, Björn Koos, Katharina Rump, et al.. (2024). Employing artificial intelligence for optimising antibiotic dosages in sepsis on intensive care unit: a study protocol for a prospective observational study (KI.SEP). BMJ Open. 14(12). e086094–e086094. 3 indexed citations
3.
Rahmel, Tim, Hartmuth Nowak, Björn Ellger, et al.. (2024). The Association between the rs3747406 Polymorphism in the Glucocorticoid-Induced Leucine Zipper Gene and Sepsis Survivals Depends on the SOFA Score. International Journal of Molecular Sciences. 25(7). 3871–3871.
4.
Thomas‐Rüddel, Daniel, Michael Bauer, Luís F. Moita, et al.. (2024). Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial. BMJ Open. 14(4). e075158–e075158.
5.
Unterberg, Matthias, Björn Koos, Tim Rahmel, & Michael Adamzik. (2024). Immunmetabolismus in der Sepsis. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 59(2). 78–94. 1 indexed citations
6.
Rump, Katharina, Lars Bergmann, Hartmuth Nowak, et al.. (2022). Midazolam impacts acetyl—And butyrylcholinesterase genes: An epigenetic explanation for postoperative delirium?. PLoS ONE. 17(7). e0271119–e0271119. 14 indexed citations
7.
Rump, Katharina, Alexander Wolf, Tim Rahmel, et al.. (2022). AQP5-1364A/C Polymorphism Affects AQP5 Promoter Methylation. International Journal of Molecular Sciences. 23(19). 11813–11813. 8 indexed citations
8.
Rump, Katharina, Matthias Unterberg, Hartmuth Nowak, et al.. (2022). The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis. Cells. 11(19). 3020–3020. 4 indexed citations
9.
Nowak, Hartmuth, Alexander Wolf, Tim Rahmel, et al.. (2022). Therapeutic Suggestions During General Anesthesia Reduce Postoperative Nausea and Vomiting in High-Risk Patients – A Post hoc Analysis of a Randomized Controlled Trial. Frontiers in Psychology. 13. 898326–898326. 10 indexed citations
10.
Koos, Björn, et al.. (2020). LPS-Induced Endotoxemia Evokes Epigenetic Alterations in Mitochondrial DNA That Impacts Inflammatory Response. Cells. 9(10). 2282–2282. 12 indexed citations
11.
12.
Rahmel, Tim, Max Hübner, Björn Koos, et al.. (2020). Impact of carbohydrate-reduced nutrition in septic patients on ICU: study protocol for a prospective randomised controlled trial. BMJ Open. 10(7). e038532–e038532. 9 indexed citations
13.
Nowak, Hartmuth, Nina Zech, Sven Asmussen, et al.. (2020). Effect of therapeutic suggestions during general anaesthesia on postoperative pain and opioid use: multicentre randomised controlled trial. BMJ. 371. m4284–m4284. 47 indexed citations
14.
15.
Rahmel, Tim, et al.. (2020). Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare. PLoS ONE. 15(2). e0228952–e0228952. 49 indexed citations
16.
Rahmel, Tim, Katharina Rump, Jürgen Peters, & Michael Adamzik. (2019). Aquaporin 5 –1364A/C Promoter Polymorphism Is Associated with Pulmonary Inflammation and Survival in Acute Respiratory Distress Syndrome. Anesthesiology. 130(3). 404–413. 17 indexed citations
17.
Koos, Björn, Matthias Unterberg, Tim Rahmel, et al.. (2019). A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes. PLoS ONE. 14(5). e0217269–e0217269. 10 indexed citations
18.
19.
Rahmel, Tim, Katharina Rump, Michael Adamzik, Jürgen Peters, & Ulrich H. Frey. (2018). Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome. BMC Anesthesiology. 18(1). 75–75. 16 indexed citations
20.
Rahmel, Tim, et al.. (2017). Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS. BMC Anesthesiology. 17(1). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min He Breakdown of academic impact, for papers by Sung‐Hee Hwang Breakdown of academic impact, for papers by Yves Ouellette Breakdown of academic impact, for papers by Ole Koldkjær Breakdown of academic impact, for papers by Jérémie Joffre Breakdown of academic impact, for papers by Purificación Ros Breakdown of academic impact, for papers by Shiro Mishima Breakdown of academic impact, for papers by Jakob Müller Breakdown of academic impact, for papers by Satoru Kawano Breakdown of academic impact, for papers by Qianqian Zhu
Rankless by CCL
2026